NCT03523975
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03523975
Title Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Medical center RECRUITING Duarte California 91010 United States Details
University of Michigan RECRUITING Ann Arbor Michigan 48109 United States Details
The Ohio State University Comprehensive Cancer Center NOT_YET_RECRUITING Columbus Ohio 43210 United States Details
University of Virginia Cancer Center RECRUITING Charlottesville Virginia 22903 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field